A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent Cancers.
Int J Mol Sci
; 23(14)2022 Jul 08.
Article
in En
| MEDLINE
| ID: mdl-35886918
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Bispecific
/
Single-Domain Antibodies
/
Antineoplastic Agents, Immunological
Limits:
Humans
Language:
En
Journal:
Int J Mol Sci
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland